[go: up one dir, main page]

KR900017609A - 안정화된 칼시토닌 약학 조성물 - Google Patents

안정화된 칼시토닌 약학 조성물 Download PDF

Info

Publication number
KR900017609A
KR900017609A KR1019900007438A KR900007438A KR900017609A KR 900017609 A KR900017609 A KR 900017609A KR 1019900007438 A KR1019900007438 A KR 1019900007438A KR 900007438 A KR900007438 A KR 900007438A KR 900017609 A KR900017609 A KR 900017609A
Authority
KR
South Korea
Prior art keywords
calcitonin
pharmaceutical composition
solid
ethylenediamine tetraacetate
calcitonin pharmaceutical
Prior art date
Application number
KR1019900007438A
Other languages
English (en)
Other versions
KR950004697B1 (ko
Inventor
히데끼 고바야시
세이지 모찌즈끼
유지 마끼노
요시끼 스즈끼
Original Assignee
이따가끼 히로시
데이진 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이따가끼 히로시, 데이진 가부시끼가이샤 filed Critical 이따가끼 히로시
Publication of KR900017609A publication Critical patent/KR900017609A/ko
Application granted granted Critical
Publication of KR950004697B1 publication Critical patent/KR950004697B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

안정화된 칼시토닌 약학 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 칼시토닌 및 에틸렌디아민 테트라아세테이트를 함유한 수용액을 동결 건조시킴으로써 또는 칼시토닌 및 에틸렌 디아민 테트라아세테이트를 함유하는 수용액에 빈용매(poor solvent)를 가함으로써 수득되는, 치료적으로 유효한 양의 하나 이상의 칼시토닌 및 하나이상의 에틸렌디아민 테트라아세테이트를 함유하는 고체 칼시토닌 약학 조성물.
  2. 제1항에 있어서, 에틸렌디아민 테트라아세테이트가 디소듐 에틸렌디아민 테트라아세테이트인 고체 칼시토닌 약학 조성물.
  3. 제1항에 있어서, 에틸렌디아민 테트라아세테이트의 양이 칼시토닌 1IU당 0.005내지 50㎍인 고체 칼시토닌 약학 조성물.
  4. 제1항에 있어서, 비강투여제제의 형태인 고체 칼시토닌 약학 조성물.
  5. 제4항에 있어서, 비강투여제제의 형태가 경질 젤라틴 캡슐(hard gelatin capsule)인 고체 칼시토닌 약학 조성물.
  6. 제1항에 있어서, 주사제 또는 점안투여용의 형태인 고체 칼시토닌 약학 조성물.
    ※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.
KR1019900007438A 1989-05-23 1990-05-23 안정화된 칼시토닌 약학 조성물 KR950004697B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1-127743 1989-05-23
JP1127743A JP2514249B2 (ja) 1989-05-23 1989-05-23 安定化されたカルシトニン類医薬組成物

Publications (2)

Publication Number Publication Date
KR900017609A true KR900017609A (ko) 1990-12-19
KR950004697B1 KR950004697B1 (ko) 1995-05-04

Family

ID=14967589

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900007438A KR950004697B1 (ko) 1989-05-23 1990-05-23 안정화된 칼시토닌 약학 조성물

Country Status (10)

Country Link
US (1) US5211950A (ko)
EP (1) EP0399781B1 (ko)
JP (1) JP2514249B2 (ko)
KR (1) KR950004697B1 (ko)
AT (1) ATE83667T1 (ko)
AU (1) AU635740B2 (ko)
CA (1) CA2017285C (ko)
DE (1) DE69000640T2 (ko)
DK (1) DK0399781T3 (ko)
ES (1) ES2053109T3 (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0489217A1 (en) * 1990-12-05 1992-06-10 Dr. A. Tosi Farmaceutici S.R.L. Calcitonin compositions for intranasal administration
JP3179538B2 (ja) * 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト 安定なヒトカルシトニンの水性溶液
IT1244500B (it) * 1991-03-21 1994-07-15 Pulitzer Italiana Impiego di sali minerali di trometamina in composizioni farmaceutiche a base di calcitonina somministrabili per via rettale in terapia umana
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
GB9623205D0 (en) 1996-11-07 1997-01-08 Eurand Int Novel pharmaceutical compositions
KR20010006361A (ko) 1997-04-14 2001-01-26 아사이 이페이 경점막 투여 제제
US7402559B2 (en) * 1999-03-24 2008-07-22 Msh Pharma, Incorporated Composition and method of treatment for urogenital conditions
CN1198611C (zh) * 1999-09-17 2005-04-27 第一三得利制药株式会社 药物抗菌剂组合物
US7812120B2 (en) * 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
AU2003901515A0 (en) * 2003-04-02 2003-04-17 Norika Holdings Sterilisation process for pharmaceutical product
US7648965B2 (en) * 2004-05-14 2010-01-19 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364659A1 (fr) * 1976-09-21 1978-04-14 Commissariat Energie Atomique Medicament antagoniste de l'action de la gastrine et des polypeptides apparentes
US4241051A (en) * 1977-11-04 1980-12-23 Christie Robert B Calcitonin
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
US4663309A (en) * 1983-06-29 1987-05-05 University Patents, Inc. Novel peptide hormones with calcitonin-like activity
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
IT1204400B (it) * 1986-06-20 1989-03-01 Sclavo Spa Composizioni farmaceutiche contenente una calcitonina
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina

Also Published As

Publication number Publication date
EP0399781A1 (en) 1990-11-28
CA2017285C (en) 1996-12-10
AU5580290A (en) 1990-11-29
ES2053109T3 (es) 1994-07-16
KR950004697B1 (ko) 1995-05-04
ATE83667T1 (de) 1993-01-15
CA2017285A1 (en) 1990-11-23
DE69000640T2 (de) 1993-04-22
JPH02306921A (ja) 1990-12-20
EP0399781B1 (en) 1992-12-23
DE69000640D1 (de) 1993-02-04
DK0399781T3 (da) 1993-02-01
AU635740B2 (en) 1993-04-01
US5211950A (en) 1993-05-18
JP2514249B2 (ja) 1996-07-10

Similar Documents

Publication Publication Date Title
KR900017609A (ko) 안정화된 칼시토닌 약학 조성물
KR920009389A (ko) 외용 피부학적 조성물
ATE62416T1 (de) Stabilisierte injektionsloesungen von piroxicam.
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
DE69521693D1 (de) Taxanderivate enthaltende arzneizubereitungen
KR910011244A (ko) 로젠지제
KR880001283A (ko) 제약 조성물
ID22763A (id) Komposisi penstabil tibolon
KR910005876A (ko) 모세혈관 취약증의 치료를 위한 극소용 약학적 조성물
DE3863859D1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
KR870007699A (ko) 약용과 화장용으로 대표적으로 사용되는 제제형의 즉석제조용 조성물
KR900001715A (ko) Bu-3608 유도체
KR900002774A (ko) 주사제
MY102411A (en) Nasal solutions
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
UA26442C2 (uk) Фармкомпозиція для профілактики і лікуваhhя захворюваhь, пов'язаhих з порушеhhям обміhу речовиh
KR890009395A (ko) 흡입제
KR910000165A (ko) 비경구 투여용 fr 115224 물질의 제제
KR880000094A (ko) 위염치료제
ATE76754T1 (de) Pharmazeutische zusammensetzung zur milderung der nebenwirkungen von platinhaltigen arzneimitteln.
KR840004120A (ko) 아즈렌 유도체의 안정화 아즈렌 유도체의 안정화방법
ATE88629T1 (de) Kosmetische un paramedizinische praeparate.
KR910700263A (ko) 시클로리노펩티드를 포함하는 의약
KR920011500A (ko) 느릅나무 추출물을 함유하는 항종양 조성물
KR890009386A (ko) 백금화합물 동결건조제제

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19900523

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19901005

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19900523

Comment text: Patent Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19930128

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19930823

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19930128

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

PJ2001 Appeal

Appeal kind category: Appeal against decision to decline refusal

Decision date: 19950330

Appeal identifier: 1993201001888

Request date: 19930923

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19950411

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 19950719

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19950925

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19950925

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19980325

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19990429

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20000422

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20010507

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20020429

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20030502

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20040429

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20050502

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20060508

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20070502

Start annual number: 13

End annual number: 13

FPAY Annual fee payment

Payment date: 20080502

Year of fee payment: 14

PR1001 Payment of annual fee

Payment date: 20080502

Start annual number: 14

End annual number: 14

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee